FMI
XERS icon

F/M Investments’s Xeris Biopharma Holdings XERS Stock Holding History

F/M Investments’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-207,543
Closed -$1.2M – 381
2026
Q1 		$1.2M Buy
+207,543
New +$1.38M 0.08% 151

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

F/M Investments's XERS Position: Q2 2026 in Review

F/M Investments sold out of Xeris Biopharma Holdings (XERS) in Q2 2026, closing a stake of 207,543 shares — an estimated $1.2M sold.

F/M Investments first reported a position in XERS in Q1 2026 and held it in 1 quarter. The position peaked at $1.2M in Q1 2026. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • F/M Investments reported no remaining Xeris Biopharma Holdings position as of Q2 2026 after selling out during the quarter.
  • F/M Investments sold 207,543 Xeris Biopharma Holdings shares in Q2 2026, an estimated $1.2M.
  • F/M Investments first reported a position in Xeris Biopharma Holdings in Q1 2026 and held it in 1 quarter.
  • F/M Investments's Xeris Biopharma Holdings position peaked at $1.2M in Q1 2026.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on F/M Investments's 13F filing for Q2 2026, filed 5 Aug 2026.